Gary W Pace Cardiff Oncology, Inc. (CRDF) insider trading activity

CRDF Quotes by TradingView

Gary W Pace is Director of Cardiff Oncology, Inc.. Currently has a direct ownership of 697,761 shares of CRDF, which is worth approximately $2.18 Million. The most recent transaction as insider was on Dec 19, 2023, when has been sold 30,000 shares (Common Stock) at a price of $1.37 per share, resulting in proceeds of $41,100. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 698K
0% 3M change
8.21% 12M change
Total Value Held $2.18 Million

GARY W PACE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 19 2023
BUY
Open market or private purchase
$41,100 $1.37 p/Share
30,000 Added 4.12%
697,761 Common Stock
Sep 15 2022
BUY
Open market or private purchase
$256,500 $1.71 p/Share
150,000 Added 18.87%
644,811 Common Stock
Sep 21 2021
BUY
Open market or private purchase
$202,500 $6.75 p/Share
30,000 Added 5.72%
494,811 Common Stock
Mar 23 2021
BUY
Open market or private purchase
$102,400 $10.24 p/Share
10,000 Added 2.11%
464,811 Common Stock
Mar 18 2021
BUY
Open market or private purchase
$31,680 $10.56 p/Share
3,000 Added 0.66%
454,811 Common Stock
Mar 04 2021
BUY
Open market or private purchase
$13,905 $9.27 p/Share
1,500 Added 0.33%
451,811 Common Stock

Also insider at

PCRX
Pacira BioSciences, Inc. Healthcare
Director
GWP

Gary W Pace

Director
San Diego, CA

Track Institutional and Insider Activities on CRDF

Follow Cardiff Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRDF shares.

Notify only if

Insider Trading

Get notified when an Cardiff Oncology, Inc. insider buys or sells CRDF shares.

Notify only if

News

Receive news related to Cardiff Oncology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRDF